Global leishmaniasis surveillance updates 2025

Overview

This report on global leishmaniasis surveillance follows those published in 2016–2025. Six leishmaniasis indicators are publicly available from the Global Health Observatory (GHO). Country profiles with up to 30 indicators are also published, using detailed data received from 45 Member States.

This report updates the GHO leishmaniasis indicators reported by Member States to WHO through 2025. It describes age and gender distribution, relapse, visceral leishmaniasis (VL) case fatality rates (CFRs) and the burden of post-kala-azar dermal leishmaniasis (PKDL). It also covers treatment regimens and outcomes for VL, HIV–VL coinfection, the kala-azar elimination programme in South-East Asia and the VL elimination initiative in eastern Africa. Updates on animal reservoir control interventions in the Americas and WHO-facilitated supplies of quality-assured health products are also included.